The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Cytokines in CAR T Cell–Associated Neurotoxicity
Open accessAbstract
Chimeric antigen receptor (CAR) T cells provide new therapeutic options for patients with relapsed/refractory hematologic malignancies. However, neurotoxicity is a frequent, and potentially fatal, complication. The spectrum of manifestations ranges from delirium and language dysfunction to seizures, coma, and fatal cerebral edema. This novel syndrome has been designated immune effector cell–associated neurotoxicity syndrome (ICANS). In this review, we draw an arc from our current understanding of how systemic and potentially local cytokine release act on the CNS, toward possible preventive and therapeutic approaches. We systematically review reported correlations of secreted inflammatory mediators in the serum/plasma and cerebrospinal fluid with the risk of ICANS in patients receiving CAR T cell therapy. Possible pathophysiologic impacts on the CNS are covered in detail for the most promising candidate cytokines, including IL-1, IL-6, IL-15, and GM-CSF. To provide insight into possible final common pathways of CNS inflammation, we place ICANS into the context of other systemic inflammatory conditions that are associated with neurologic dysfunction, including sepsis-associated encephalopathy, cerebral malaria, thrombotic microangiopathy, CNS infections, and hepatic encephalopathy. We then review in detail what is known about systemic cytokine interaction with components of the neurovascular unit, including endothelial cells, pericytes, and astrocytes, and how microglia and neurons respond to systemic inflammatory challenges. Current therapeutic approaches, including corticosteroids and blockade of IL-1 and IL-6 signaling, are reviewed in the context of what is known about the role of cytokines in ICANS. Throughout, we point out gaps in knowledge and possible new approaches for the investigation of the mechanism, prevention, and treatment of ICANS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Mumm, J. B., & Oft, M. (2013) · BioEssays · doi:10.1002/bies.201300004 · Cited by 53
Interferon-γ Safeguards Blood-Brain Barrier during Experimental Autoimmune Encephalomyelitis
Chen, N., Wang, C., Zhang, J., Qu, L.-W., Liu, X., Lu, Y., Yang, W. C., Deng, J., Lorenz, D., Gao, P., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.019 · Cited by 53
Stein, A. S., Franklin, J. L., Chia, V. M., Arrindell, D., Kormany, W. N., Wright, J., Parson, M., Amouzadeh, H. R., Choudhry, J., & Joseph, G. L. (2018) · Drug Safety · doi:10.1007/s40264-018-0760-1 · Cited by 53
Toxicity as a result of immunostimulation by biologics
Gribble, E. J., Sivakumar, P. V., Ponce, R. A., & Hughes, S. D. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.2.209 · Cited by 52
Self-citationAcute Multiple Sclerosis Relapse
Berkovich, R. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000330 · Cited by 52
Desch, K. C., & Motto, D. G. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010062 · Cited by 48
Long-Term Microgliosis Driven by Acute Systemic Inflammation
Trzeciak, A. J., Lerman, Y. V., Kim, T., Kim, M. R., Mai, N., Halterman, M. W., & Kim, M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900317 · Cited by 45
Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome
Stahl, K., Schmidt, B. M. W., Hoeper, M. M., Skripuletz, T., Möhn, N., Beutel, G., Eder, M., Welte, T., Ganser, A., Falk, C. S., et al. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.02.010 · Cited by 45
Bessler, H., Mendel, C., Straussberg, R., Gurary, N., Aloni, D., & Sirota, L. (1999) · Neonatology · doi:10.1159/000014099 · Cited by 43
Blocki, A. M., Beyer, S., Jung, F., & Raghunath, M. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189132 · Cited by 42
CAR T-Cell-Associated Neurotoxicity: Current Management and Emerging Treatment Strategies
Rivera, A., May, S., Lei, M. M., Qualls, S., Bushey, K., Rubin, D. B., & Barra, M. E. (2020) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000302 · Cited by 40
Grupp, S. A., Hu, Z., Zhang, Y., Keating, A. K., Pulsipher, M. A., Phillips, C. L., Margossian, S. P., Rosenthal, J., Salzberg, D. B., Schiff, D. E., et al. (2019) · Blood · doi:10.1182/blood-2019-129279 · Cited by 39
Prapansilp, P., Medana, I. M., Hoàn, N. T., Day, N., Phu, N. H., Yeo, T. W., Hien, T. T., White, N. J., Anstey, N. M., & Turner, G. D. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-50 · Cited by 38
Harawa, V., Njie, M., Kessler, A., Choko, A. T., Kumwenda, B., Kampondeni, S., Potchen, M. J., Kim, K., Jaworowski, A., Taylor, T. E., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2590-0 · Cited by 34
Carvajal, R., Sato, T., Shoushtari, A., Sacco, J., Nathan, P., Orloff, M., Corrie, P., Steven, N., Evans, J., Infante, J., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0289-3 · Cited by 34
Drug‐induced in vitro inhibition of neutrophil‐endothelial cell adhesion
Pellegatta, F., Lu, Y., Radaelli, A., Zocchi, M. R., Ferrero, E., Chierchia, S. L., Gaja, G., & Ferrero, M. E. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15427.x · Cited by 29
Shah, B. D., Huynh, V., Sender, L. S., Lee, D. W., Castro, J. E., Wierda, W. G., Dietz, A. C., Schiller, G. J., Kersten, M. J., Handgretinger, R., et al. (2016) · Blood · doi:10.1182/blood.v128.22.2803.2803 · Cited by 29
Beginning the CAR T cell therapy revolution in the US and EU
Grupp, S. A. (2018) · Current Research in Translational Medicine · doi:10.1016/j.retram.2018.03.004 · Cited by 29
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · Hematological Oncology · doi:10.1002/hon.2437_7 · Cited by 28
Central Nervous System Involvement in Adults with Epidemic Hemolytic Uremic Syndrome
Wengenroth, M., Hoeltje, J., Repenthin, J., Meyer, T. N., Bonk, F., Becker, H., Faiss, S., Stammel, O., Urban, P. P., & Bruening, R. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3336 · Cited by 25
Fortuna, D., Hooper, D. C., Roberts, A. L., Harshyne, L. A., Nagurney, M., & Curtis, M. T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205501 · Cited by 25
Santomasso, B., Park, J. H., Rivière, I., Mead, E., Halton, E. F., Diamonte, C., Purdon, T. J., Sénéchal, B., Li, D., Sadelain, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.3019 · Cited by 22
The Multifaceted Role of Interferon-γ in Central Nervous System Autoimmune Demyelination
Sanvito, L., Constantinescu, C. S., Gran, B., & Hart, B. A. ‘. (2010) · The Open Autoimmunity Journal · Cited by 17
Myers, R. M., Kadauke, S., Li, Y., Callahan, C. A., Gladney, W. L., Fitzgerald, J. C., Wray, L., Leahy, A. B., Baniewicz, D., Motley, L. S., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.12.105 · Cited by 16
Topp, M. S., van Meerten, T., Houot, R., Minnema, M. C., Milpied, N. J., Lugtenburg, P. J., Thiéblemont, C., Wermke, M., Song, K., Avivi, I. M., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.12.603 · Cited by 15
Neurotoxicities After CAR T-Cell Immunotherapy
Gust, J., Ceppi, F., & Turtle, C. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66181-2.00007-x · Cited by 12
Self-citation
Cited by
CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Zhang, X., Zhu, L., Zhang, H., Chen, S., & Xiao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.927153 · Cited by 396
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
Cappell, K. M., & Kochenderfer, J. N. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00530-z · Cited by 393
Xiao, X., Huang, S., Chen, S., Wang, Y., Sun, Q., Xu, X., & Li, Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02148-6 · Cited by 310
Billingsley, M. M., Gong, N., Mukalel, A. J., Thatte, A. S., El‐Mayta, R., Patel, S. K., Metzloff, A. E., Swingle, K. L., Han, X., Xue, L., et al. (2024) · Small · doi:10.1002/smll.202304378 · Cited by 268
Metadata
- Authors
- Gust, J., Ponce, R., Liles, W. C., Garden, G. A., & Turtle, C. J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-12-16
- Volume
- 11
- Pages
- 577027-577027
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3110691903
- Cited by
- 264
- References
- 226
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.